Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition.

Cancer science - 1 Mar 2024

Bando Hideaki, Yamaguchi Kyoko, Mitani Seiichiro, Sawada Kentaro, Mishima Saori, Komine Keigo, Okugawa Yoshinaga, Hosoda Waki, Ebi Hiromichi

Abstract excerpt

Molecular testing to determine optimal therapies is essential for managing patients with colorectal cancer (CRC). In October 2022, the Japanese Society of Medical Oncology published the 5th edition of the Molecular Testing Guideline for Colorectal Cancer Treatment. In this guideline, in patients with unresectable CRC, RAS/BRAF V600E mutational and mismatch repair tests are strongly recommended prior to first-line...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circulating Tumor DNA
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Medical Oncology

Share to Molecular Diagnostic Techniques

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Source

Open in PubMed Open full text

Identifiers

PMID: 38263580
DOI: 10.1111/cas.16039
PMCID: PMC10920993

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition.PMID 38263580Read ↗

Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition.Semantic proximity Read ↗

[II. Clinical Guidelines of Molecular Testing for Colorectal Cancer].Semantic proximity Read ↗

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.Semantic proximity Read ↗

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.Semantic proximity Read ↗

New Guideline on Managing Colorectal Cancer.Semantic proximity Read ↗

Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists GuidelineSemantic proximity Read ↗

Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.Semantic proximity Read ↗

Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.Semantic proximity Read ↗

Colorectal Cancer: Genetic Underpinning and Molecular Therapeutics for Precision Medicine.Semantic proximity Read ↗

Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updatesSemantic proximity Read ↗

Molecular Pathology of Colorectal CancerSemantic proximity Read ↗

Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in OncologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.